alprazolam tablet extended release
1 INDICATIONS AND USAGE Alprazolam extended-release tablets are indicated for the treatment of panic disorder with or without agoraphobia, in adults. Alprazolam extended-release tablets are a benzodiazepine indicated for the treatment of panic disorder with or without agoraphobia, in adults. ( 1 )
Aurobindo Pharma Limited
Related Pills
alprazolam tablet extended release
aurobindo pharma limited
alprazolam tablet extended release
aurobindo pharma limited
24 HR Diltiazem Hydrochloride 360 MG Extended Release Oral Capsule Taztia
Actavis Pharma, Inc.
24 HR dexmethylphenidate hydrochloride 25 MG Extended Release Oral Capsule
Amneal Pharmaceuticals of New York LLC
24 HR dexmethylphenidate hydrochloride 25 MG Extended Release Oral Capsule
Amneal Pharmaceuticals of New York LLC
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
ALPRAZOLAM Extended-Release Tablets USP are supplied in the following strengths and package configurations:
ALPRAZOLAM Extended-Release Tablets USP, 0.5 mg are white to off-white, round, biconvex tablets with beveled edge debossed with ‘X’ on one side and ‘70’ on the other side. Bottles of 60 NDC 65862-454-60 Bottles of 1,000 NDC 65862-454-99 Bottles of 7,000 NDC 65862-454-71
ALPRAZOLAM Extended-Release Tablets USP, 1 mg are yellow colored, round, biconvex tablets with beveled edge debossed with ‘X’ on one side and ‘73’ on the other side. The tablets may be mottled. Bottles of 60 NDC 65862-455-60 Bottles of 1,000 NDC 65862-455-99 Bottles of 7,000 NDC 65862-455-71
ALPRAZOLAM Extended-Release Tablets USP, 2 mg are blue colored, round, biconvex tablets with beveled edge debossed with ‘X’ on one side and ‘74’ on the other side. The tablets may be mottled. Bottles of 60 NDC 65862-456-60 Bottles of 1,000 NDC 65862-456-99 Bottles of 7,000 NDC 65862-456-71
ALPRAZOLAM Extended-Release Tablets USP, 3 mg are green colored, round, biconvex tablets with beveled edge debossed with ‘X’ on one side and ‘75’ on the other side. The tablets may be mottled. Bottles of 60 NDC 65862-457-60 Bottles of 1,000 NDC 65862-457-99 Bottles of 7,000 NDC 65862-457-71 Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
More pills like ROUND X 70